TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
LMRI

Lumexa Imaging Holdings, Inc.

Healthcare · Medical Devices

14.90$ -6.3% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns Lumexa Imaging Holdings, Inc. (LMRI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 23.0% of the shares are freely tradable; institutional investors hold 33.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 33.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 80.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 23.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 96Mio.

Largest Shareholders

Institutions

Institutions LMRI
Name Stake (%) Shares Change (%) Date
Brown Advisory Holdings Inc 6.01 5,777,574 +238.8 06/30/2026
Massachusetts Financial Services Company 3.59 3,453,723 +47.9 06/30/2026
Think Investments LP 2.66 2,559,501 +0.0 06/30/2026
Jupiter Topco LLC 2.24 2,151,538 +0.0 06/30/2026
BlackRock Inc 1.46 1,398,112 -8.4 06/30/2026
JPMorgan Chase & Co 1.20 1,154,463 +4.5 06/30/2026
Vanguard Capital Management, LLC 1.11 1,070,325 +1.1 06/30/2026

Funds

Funds LMRI
Name Stake (%) Shares Change (%) Date
Brown Advisory Small-Cap Fdmtl Val Inv 2.29 2,197,481 -1.3 09/30/2026
MFS New Discovery Value I 1.56 1,497,827 -4.6 09/30/2026
Bridge Builder Small Cap Fund 0.86 826,595 -1.1 10/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?